Terms: = Sarcomas AND MYOD1, ENSG00000129152, 4654, P15172, PUM, MYOD, MYF3 AND Prognosis
60 results:
1. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
[No Abstract] [Full Text] [Related]
2. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
[TBL] [Abstract] [Full Text] [Related]
3. sarcomas Harboring EWSR1::PATZ1 Fusions: A Clinicopathologic Study of 17 Cases.
Dehner CA; Torres-Mora J; Gupta S; Kipp BR; Halling KC; Chen S; Warmke LM; Michal M; Alani A; Yu W; Kovacs K; Obeidin F; Iwenofu OH; Satturwar S; Meis JM; Folpe AL
Mod Pathol; 2024 Feb; 37(2):100400. PubMed ID: 38043789
[TBL] [Abstract] [Full Text] [Related]
4. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
[TBL] [Abstract] [Full Text] [Related]
5. Epithelioid and spindle rhabdomyosarcoma with TFCP2 rearrangement in abdominal wall: a distinctive entity with poor prognosis.
Li Y; Li D; Wang J; Tang J
Diagn Pathol; 2023 Mar; 18(1):41. PubMed ID: 36998041
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological features and prognosis of primary pulmonary rhabdomyosarcoma in middle-aged and elderly patients: a case report and literature review.
Xiaoxia J; Guihua Z; Jiatai W; Xinghua Z; Xudong C; Yingze W
J Int Med Res; 2023 Mar; 51(3):3000605231159782. PubMed ID: 36883437
[TBL] [Abstract] [Full Text] [Related]
7. [Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation].
Tarakanova AV; Sharlay AS; Konovalov DM
Arkh Patol; 2023; 85(1):10-15. PubMed ID: 36785957
[TBL] [Abstract] [Full Text] [Related]
8. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Features and Prognostic Factors of Sinonasal Rhabdomyosarcoma.
Lo WL; Huang WH; Yeh CF
In Vivo; 2022; 36(6):2965-2972. PubMed ID: 36309350
[TBL] [Abstract] [Full Text] [Related]
10. Spindle Cell/Sclerosing Rhabdomyosarcoma of the Orbit.
Proia AD
Ophthalmic Plast Reconstr Surg; 2023 Jan-Feb 01; 39(1):e17-e20. PubMed ID: 35829629
[TBL] [Abstract] [Full Text] [Related]
11. A Rare Case of A Low-Grade Inflammatory Leiomyosarcoma/Histiocyte-Rich Rhabdomyoblastic Tumor in the Neck of An Adolescent Male.
Rekhi B; Bal M; Dharavath B; Dutt A; Pai P
Turk Patoloji Derg; 2023; 39(2):154-160. PubMed ID: 35642345
[TBL] [Abstract] [Full Text] [Related]
12. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
[TBL] [Abstract] [Full Text] [Related]
13. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and PAX7-FOXO1].
Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
[TBL] [Abstract] [Full Text] [Related]
14. Differential Diagnosis in Hypophysitis: First Report on a Spindle Cell Rhabdomyosarcoma of the Pituitary Gland.
Ahmeti H; Jüttner E; Röcken C; Jansen O; Laudes M; Synowitz M
J Neurol Surg A Cent Eur Neurosurg; 2023 May; 84(3):295-299. PubMed ID: 34781400
[TBL] [Abstract] [Full Text] [Related]
15. Clinical features and prognosis of paediatric rhabdomyosarcoma with bone marrow metastasis: a single Centre experiences in China.
Huang C; Jian B; Su Y; Xu N; Yu T; He L; Zhang X; Liu Y; Jin M; Ma X
BMC Pediatr; 2021 Oct; 21(1):463. PubMed ID: 34670517
[TBL] [Abstract] [Full Text] [Related]
16. A Review of Effusion Cytomorphology of Small Round Cell Tumors.
Han LM; VandenBussche CJ; Abildtrup M; Chandra A; Vohra P
Acta Cytol; 2022; 66(4):336-346. PubMed ID: 34218227
[TBL] [Abstract] [Full Text] [Related]
17. Establishment and characterization of NCC-ssRMS2-C1: a novel patient-derived cell line of spindle cell/sclerosing rhabdomyosarcoma.
Tsuchiya R; Yoshimatsu Y; Noguchi R; Sin Y; Ono T; Sei A; Takeshita F; Sugaya J; Nakatani F; Yoshida A; Ohtori S; Kawai A; Kondo T
Hum Cell; 2021 Sep; 34(5):1569-1578. PubMed ID: 34164773
[TBL] [Abstract] [Full Text] [Related]
18. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for myod1-mutant soft-tissue sarcoma of childhood.
Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
[TBL] [Abstract] [Full Text] [Related]
19. myod1 as a prognostic indicator in rhabdomyosarcoma.
Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG
Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590
[TBL] [Abstract] [Full Text] [Related]
20. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
[TBL] [Abstract] [Full Text] [Related]
[Next]